Compare NXE & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NXE | RNA |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 4.0B |
| IPO Year | N/A | 2020 |
| Metric | NXE | RNA |
|---|---|---|
| Price | $8.96 | $71.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 20 |
| Target Price | N/A | ★ $69.26 |
| AVG Volume (30 Days) | ★ 7.3M | 2.4M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,868,000.00 |
| Revenue This Year | N/A | $64.11 |
| Revenue Next Year | N/A | $37.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 106.27 |
| 52 Week Low | $3.91 | $21.51 |
| 52 Week High | $9.99 | $71.86 |
| Indicator | NXE | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 76.01 |
| Support Level | $8.95 | $71.18 |
| Resistance Level | $9.60 | $71.79 |
| Average True Range (ATR) | 0.45 | 0.37 |
| MACD | 0.05 | -0.62 |
| Stochastic Oscillator | 55.71 | 99.16 |
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.